These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7791695)

  • 1. [Diagnosis and therapy of Gaucher disease].
    Ehlen C; Heintges T; Niederau C
    Med Klin (Munich); 1995 May; 90(5):284-90. PubMed ID: 7791695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.
    Altarescu G; Schiffmann R; Parker CC; Moore DF; Kreps C; Brady RO; Barton NW
    Blood Cells Mol Dis; 2000 Aug; 26(4):285-90. PubMed ID: 11042029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease.
    Schiffmann R; Heyes MP; Aerts JM; Dambrosia JM; Patterson MC; DeGraba T; Parker CC; Zirzow GC; Oliver K; Tedeschi G; Brady RO; Barton NW
    Ann Neurol; 1997 Oct; 42(4):613-21. PubMed ID: 9382473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [French results of enzyme replacement therapy in Gaucher's disease].
    Schaison G; Caubel I; Belmatoug N; Billette de Villemeur T; Saudubray JM
    Bull Acad Natl Med; 2002; 186(5):851-61; discussion 861-3. PubMed ID: 12412377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J; Szücs FZ; Benkö K; Maródi L
    Orv Hetil; 2003 Apr; 144(16):749-55. PubMed ID: 12778625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enzyme replacement therapy in type 1 Gaucher's disease].
    Aggio MC; Fernández V; Marcilese M
    Medicina (B Aires); 1994; 54(2):140-4. PubMed ID: 7997130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of bone marrow failure in Gaucher's disease with low-dose modified glucocerebrosidase.
    Mistry PK; Davies S; Corfield A; Dixon AK; Cox TM
    Q J Med; 1992 Jul; 83(303):541-6. PubMed ID: 1484931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gaucher's disease: a review.
    Morales LE
    Ann Pharmacother; 1996 Apr; 30(4):381-8. PubMed ID: 8729893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveitis in Gaucher disease.
    Dweck A; Rozenman J; Ronen S; Zimran A; Elstein D
    Am J Ophthalmol; 2005 Jul; 140(1):146-7. PubMed ID: 16038664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gaucher disease: diagnosis and treatment].
    Fumić K; Stavljenić-Rukavina A; Mrsić M; Potocki K
    Acta Med Croatica; 2004; 58(5):353-8. PubMed ID: 15756799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gaucher's disease: pathogenesis, diagnosis and therapy].
    Pregun I; Tulassay Z
    Orv Hetil; 2004 Sep; 145(37):1883-90. PubMed ID: 15493618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Enzyme replacement therapy: a new treatment concept in Gaucher disease].
    Beck M; Mengel E; Barone R
    Wien Klin Wochenschr; 1997 Feb; 109(3):81-5. PubMed ID: 9139464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic analysis of a novel enzyme replacement therapy with Gene-Activated human glucocerebrosidase (GA-GCB) in patients with type 1 Gaucher disease.
    Zimran A; Loveday K; Fratazzi C; Elstein D
    Blood Cells Mol Dis; 2007; 39(1):115-8. PubMed ID: 17391996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.
    Barton NW; Brady RO; Dambrosia JM; Di Bisceglie AM; Doppelt SH; Hill SC; Mankin HJ; Murray GJ; Parker RI; Argoff CE
    N Engl J Med; 1991 May; 324(21):1464-70. PubMed ID: 2023606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaucher's disease: a review for the internist and hepatologist.
    Niederau C; Häussinger D
    Hepatogastroenterology; 2000; 47(34):984-97. PubMed ID: 11020862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gaucher disease type 1--therapeutic results of enzyme substitution].
    Steensberg J; Nielsen KG; Brandt NJ
    Ugeskr Laeger; 1998 Jun; 160(26):3929-30. PubMed ID: 9656836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First long-term results of imiglucerase therapy of type 1 Gaucher disease.
    Niederau C; vom Dahl S; Häussinger D
    Eur J Med Res; 1998 Feb; 3(1-2):25-30. PubMed ID: 9512964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gaucher's disease].
    Livandovskiĭ IuA; Kapustina ND; Beĭer EM
    Klin Med (Mosk); 1991 Apr; 69(4):87-9. PubMed ID: 1865664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease.
    Lonser RR; Walbridge S; Murray GJ; Aizenberg MR; Vortmeyer AO; Aerts JM; Brady RO; Oldfield EH
    Ann Neurol; 2005 Apr; 57(4):542-8. PubMed ID: 15786474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gaucher's disease and enzyme replacement therapy].
    Cornu F
    Ann Pharm Fr; 1998; 56(3):102-7. PubMed ID: 9770016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.